YHB Investment Advisors Inc. lifted its stake in CME Group Inc (NASDAQ:CME) by 10.5% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 30,557 shares of the financial services provider’s stock after purchasing an additional 2,894 shares during the quarter. YHB Investment Advisors Inc.’s holdings in CME Group were worth $5,748,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors also recently added to or reduced their stakes in CME. Prime Capital Investment Advisors LLC raised its stake in shares of CME Group by 282.5% during the 3rd quarter. Prime Capital Investment Advisors LLC now owns 765 shares of the financial services provider’s stock worth $130,000 after purchasing an additional 565 shares in the last quarter. Honkamp Krueger Financial Services Inc. purchased a new stake in shares of CME Group during the 3rd quarter worth about $132,000. Moody National Bank Trust Division purchased a new stake in shares of CME Group during the 4th quarter worth about $133,000. Bbva Compass Bancshares Inc. purchased a new stake in shares of CME Group during the 3rd quarter worth about $134,000. Finally, Buckley Wealth Management LLC purchased a new stake in shares of CME Group during the 3rd quarter worth about $201,000. Institutional investors and hedge funds own 85.73% of the company’s stock.
Shares of CME Group stock traded up $0.70 during trading on Friday, reaching $180.55. 1,315,009 shares of the company were exchanged, compared to its average volume of 1,905,944. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.15. CME Group Inc has a twelve month low of $149.38 and a twelve month high of $197.08. The stock has a market cap of $60.69 billion, a PE ratio of 37.85, a price-to-earnings-growth ratio of 2.21 and a beta of 0.43.
The firm also recently announced a dividend, which will be paid on Wednesday, January 16th. Shareholders of record on Friday, December 28th will be paid a $1.75 dividend. The ex-dividend date is Thursday, December 27th. CME Group’s payout ratio is 58.70%.
CME has been the topic of a number of recent analyst reports. Zacks Investment Research raised CME Group from a “sell” rating to a “hold” rating in a research note on Tuesday, September 18th. Berenberg Bank set a $184.00 target price on CME Group and gave the company a “hold” rating in a report on Thursday, September 20th. Jefferies Financial Group raised their target price on CME Group to $203.00 and gave the company a “buy” rating in a report on Monday, October 8th. BidaskClub upgraded CME Group from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, October 9th. Finally, Deutsche Bank reiterated a “buy” rating and issued a $192.00 price objective (up previously from $185.00) on shares of CME Group in a research report on Thursday, October 11th. Eight analysts have rated the stock with a hold rating and ten have given a buy rating to the company. CME Group has a consensus rating of “Buy” and an average target price of $193.00.
In other CME Group news, insider Julie Winkler sold 5,847 shares of the business’s stock in a transaction dated Friday, November 16th. The stock was sold at an average price of $195.01, for a total value of $1,140,223.47. Following the completion of the transaction, the insider now directly owns 24,255 shares of the company’s stock, valued at $4,729,967.55. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO John W. Pietrowicz sold 17,960 shares of the business’s stock in a transaction dated Wednesday, January 2nd. The shares were sold at an average price of $186.92, for a total value of $3,357,083.20. Following the completion of the transaction, the chief financial officer now directly owns 44,780 shares of the company’s stock, valued at $8,370,277.60. The disclosure for this sale can be found here. Over the last three months, insiders sold 58,647 shares of company stock valued at $11,107,550. Insiders own 0.43% of the company’s stock.
CME Group Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Featured Story: Buyback
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.